King Pharmaceuticals KG International — Reverse for loss and loss adjustment expenses

Other product segments

Similar metrics at other companies

TITNInternational — Accounts Receivable, Credit Loss Expense (Reversal)

$287K+57.7%

CNAInternational — Reinsurance receivables

$575M+3.0%

HGInternational — Future policy benefits, losses, claims and loss adjustment expenses

$2.35B+20.2%

HGInternational - Casualty — Liabilities for unpaid losses and loss adjustment expenses, net of reinsurance

$686.27M+30.9%

HGInternational - Specialty — Unpaid losses and loss adjustment expenses recoverable

$206.25M-2.2%

HGInternational - Property — Liabilities for unpaid losses and loss adjustment expenses, net of reinsurance

$114.42M+3.4%

Questions, answered.

What is King Pharmaceuticals's international — reverse for loss and loss adjustment expenses?

King Pharmaceuticals (KG) reported international — reverse for loss and loss adjustment expenses of $28.77M in Q4 2025.

What does international — reverse for loss and loss adjustment expenses mean?

This represents the total reserve balance maintained by the international segment to cover future payments for both reported and unreported losses, including associated adjustment expenses. It is a fundamental measure of the segment's financial health and its ability to meet long-term policyholder obligations. Changes in this reserve balance often signal shifts in actuarial assumptions or underlying claim trends.